| Literature DB >> 31132431 |
Ying Liu1, Wei Ding2, Hu Ge3, Murugavel Ponnusamy1, Qiong Wang4, Xiaodan Hao1, Wei Wu1, Yuan Zhang1, Wanpeng Yu1, Xiang Ao5, Jianxun Wang6.
Abstract
Growing evidence suggests that alterations of gene expression including expression and activities of transcription factors are closely associated with carcinogenesis. Forkhead Box Class K (FOXK) proteins, FOXK1 and FOXK2, are a family of evolutionarily conserved transcriptional factors, which have recently been recognized as key transcriptional regulators involved in many types of cancer. Members of the FOXK family mediate a wide spectrum of biological processes, including cell proliferation, differentiation, apoptosis, autophagy, cell cycle progression, DNA damage and tumorigenesis. Therefore, the deregulation of FOXKs can affect the cell fate and they promote tumorigenesis as well as cancer progression. The mechanisms of FOXKs regulation including post-translational modifications (PTMs), microRNAs (miRNAs) and protein-protein interactions are well demonstrated. However, the detailed mechanisms of FOXKs activation and deregulation in cancer progression are still inconclusive. In this review, we summarize the regulatory mechanisms of FOXKs expression and activity, and their role in the development and progression of cancer. We have discussed whether FOXKs act as tumor suppressors/oncoproteins in tumor cells and their therapeutic applications in malignant diseases are also discussed. This review may assist in designing experimental studies involving FOXKs and it would strength the therapeutic potential of FOXKs as targets for cancers.Entities:
Keywords: Biomarker; FOXK1; FOXK2; Therapeutic target; ncRNAs
Mesh:
Substances:
Year: 2019 PMID: 31132431 DOI: 10.1016/j.canlet.2019.05.030
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679